|
1
|
Zhu B, Zhang J, Wang X, Chen J and Li C:
Correlation between acute myeloid leukemia and IL-17A, IL-17F, and
IL-23R gene polymorphism. Int J Clin Exp Pathol. 8:5739–5743.
2015.PubMed/NCBI
|
|
2
|
Quotti Tubi L, Canovas Nunes S, Brancalion
A, Doriguzzi Breatta E, Manni S, Mandato E, Zaffino F, Macaccaro P,
Carrino M, Gianesin K, et al: Protein kinase CK2 regulates AKT,
NF-κB and STAT3 activation, stem cell viability and proliferation
in acute myeloid leukemia. Leukemia. 31:292–300. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Godwin CD, Gale RP and Walter RB:
Gemtuzumab ozogamicin in acute myeloid leukemia. Leukemia.
31:1855–1868. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Belson M, Kingsley B and Holmes A: Risk
factors for acute leukemia in children: A review. Environ Health
Perspect. 115:138–145. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Estey E and Dohner H: Acute myeloid
leukaemia. Lancet. 368:1894–1907. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schuz J and Erdmann F: Environmental
exposure and risk of childhood leukemia: An overview. Arch Med Res.
47:607–614. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yin F, Shu L, Liu X, Li T, Peng T, Nan Y,
Li S, Zeng X and Qiu X: Microarray-based identification of genes
associated with cancer progression and prognosis in hepatocellular
carcinoma. J Exp Clin Cancer Res. 35:1272016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yin F, Yi S, Wei L, Zhao B, Li J, Cai X,
Dong C and Liu X: Microarray-based identification of genes
associated with prognosis and drug resistance in ovarian cancer. J
Cell Biochem. 120:6057–6070. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Raich T and Powell S: Identification of
bacterial and fungal pathogens from positive blood culture bottles:
A microarray-based approach. Methods Mol Biol. 1237:73–90. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stirewalt DL, Meshinchi S, Kopecky KJ, Fan
W, Pogosova-Agadjanyan EL, Engel JH, Cronk MR, Dorcy KS, McQuary
AR, Hockenbery D, et al: Identification of genes with abnormal
expression changes in acute myeloid leukemia. Genes Chromosomes
Cancer. 47:8–20. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stegmaier K, Ross KN, Colavito SA,
O'Malley S, Stockwell BR and Golub TR: Gene expression-based
high-throughput screening (GE-HTS) and application to leukemia
differentiation. Nat Genet. 36:257–263. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haferlach T, Kohlmann A, Wieczorek L,
Basso G, Kronnie GT, Béné MC, De Vos J, Hernández JM, Hofmann WK,
Mills KI, et al: Clinical utility of microarray-based gene
expression profiling in the diagnosis and subclassification of
leukemia: Report from the International Microarray Innovations in
Leukemia Study Group. J Clin Oncol. 28:2529–2537. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang YX, Zhang TJ, Yang DQ, Yao DM, Yang
L, Zhou JD, Deng ZQ, Ma JC, Guo H, Wen XM, et al: Reduced miR-215
expression predicts poor prognosis in patients with acute myeloid
leukemia. Jpn J Clin Oncol. 46:350–356. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ryotokuji T, Yamaguchi H, Ueki T, Usuki K,
Kurosawa S, Kobayashi Y, Kawata E, Tajika K, Gomi S, Kanda J, et
al: Clinical characteristics and prognosis of acute myeloid
leukemia associated with DNA-methylation regulatory gene mutations.
Haematologica. 101:1074–1081. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gal H, Amariglio N, Trakhtenbrot L,
Jacob-Hirsh J, Margalit O, Avigdor A, Nagler A, Tavor S, Ein-Dor L,
Lapidot T, et al: Gene expression profiles of AML derived stem
cells; similarity to hematopoietic stem cells. Leukemia.
20:2147–2154. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Metzeler KH, Hummel M, Bloomfield CD,
Spiekermann K, Braess J, Sauerland MC, Heinecke A, Radmacher M,
Marcucci G, Whitman SP, et al: An 86-probe-set gene-expression
signature predicts survival in cytogenetically normal acute myeloid
leukemia. Blood. 112:4193–4201. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Delas MJ, Sabin LR, Dolzhenko E, Knott SR,
Munera Maravilla E, Jackson BT, Wild SA, Kovacevic T, Stork EM,
Zhou M, et al: lncRNA requirements for mouse acute myeloid leukemia
and normal differentiation. ELife. 6(pii): e256072017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meyer SE, Qin T, Muench DE, Masuda K,
Venkatasubramanian M, Orr E, Suarez L, Gore SD, Delwel R, Paietta
E, et al: DNMT3A haploinsufficiency transforms FLT3ITD
myeloproliferative disease into a rapid, spontaneous, and fully
penetrant acute myeloid leukemia. Cancer Ddiscov. 6:501–515. 2016.
View Article : Google Scholar
|
|
23
|
Salvestrini V, Zini R, Rossi L, Gulinelli
S, Manfredini R, Bianchi E, Piacibello W, Caione L, Migliardi G,
Ricciardi MR, et al: Purinergic signaling inhibits human acute
myeloblastic leukemia cell proliferation, migration, and
engraftment in immunodeficient mice. Blood. 119:217–226. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Austin R, Smyth MJ and Lane SW: Harnessing
the immune system in acute myeloid leukaemia. Crit Rev Oncol
Hematol. 103:62–77. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Davidson-Moncada J, Viboch E, Church SE,
Warren SE and Rutella S: Dissecting the immune landscape of acute
myeloid leukemia. Biomedicines. 6(pii): E1102018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dietrich MA, Slowinska M, Karol H, Adamek
M, Steinhagen D, Hejmej A, Bilińska B and Ciereszko A: Serine
protease inhibitor Kazal-type 2 is expressed in the male
reproductive tract of carp with a possible role in antimicrobial
protection. Fish Shellfish Immunol. 60:150–163. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kherraf ZE, Christou-Kent M, Karaouzene T,
Amiri-Yekta A, Martinez G, Vargas AS, Lambert E, Borel C, Dorphin
B, Aknin-Seifer I, et al: SPINK2 deficiency causes infertility by
inducing sperm defects in heterozygotes and azoospermia in
homozygotes. EMBO Mol Med. 9:1132–1149. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee B, Park I, Jin S, Choi H, Kwon JT, Kim
J, Jeong J, Cho BN, Eddy EM and Cho C: Impaired spermatogenesis and
fertility in mice carrying a mutation in the Spink2 gene expressed
predominantly in testes. J Biol Chem. 286:29108–29117. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hoefnagel JJ, Dijkman R, Basso K, Jansen
PM, Hallermann C, Willemze R, Tensen CP and Vermeer MH: Distinct
types of primary cutaneous large B-cell lymphoma identified by gene
expression profiling. Blood. 105:3671–3678. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen T, Lee TR, Liang WG, Chang WS and Lyu
PC: Identification of trypsin-inhibitory site and structure
determination of human SPINK2 serine proteinase inhibitor.
Proteins. 77:209–219. 2009. View Article : Google Scholar : PubMed/NCBI
|
